Cerenia (maropitant citrate) Tablets 160 mg, 4 ct.Cerenia is a veterinary prescription medication classified as a neurokinin-1 (NK1) receptor antagonist. It is the first and only FDA-approved treatment to prevent vomiting due to motion sickness in dogs. By
Cerenia (maropitant citrate) Tablets 160 mg, 4 ct.
Cerenia is a veterinary prescription medication classified as a neurokinin-1 (NK1) receptor antagonist. It is the first and only FDA-approved treatment to prevent vomiting due to motion sickness in dogs. By blocking signals to the vomiting center in the brain, Cerenia provides safe, effective, and non-sedating relief, helping dogs travel more comfortably.
Key Details:
Strength & Count: 160 mg tablets; 4 ct.
Class: NK1 receptor antagonist (antiemetic).
Indication (Dogs): Prevention of vomiting due to motion sickness in dogs 16 weeks of age and older; prevention of acute vomiting in dogs 8 weeks of age and older (for up to 5 consecutive days).
Feline Safety: Not approved for cats.
Use Only Under Vet Supervision: Federal law restricts this drug to use by or on the order of a licensed veterinarian. Not for human use. In case of accidental ingestion, seek medical attention immediately. Wash hands after handling; may cause localized skin reactions or eye irritation with accidental exposure. Use caution in dogs with hepatic dysfunction or when used with other highly protein-bound drugs. May cause dose-related decreases in appetite and body weight.
Contraindications/Cautions: Not evaluated for use in breeding, pregnant, or lactating dogs. Not evaluated in dogs with gastrointestinal obstruction or toxin ingestion. Not for puppies under 8 weeks (acute vomiting) or under 16 weeks (motion sickness).
Storage: Store at 6877F (2025C).
Regulatory: Prescription required; federal law restricts this drug to use by or on the order of a licensed veterinarian.
Keep away from children and other household pets.
This item is not returnable or refundable.
Sold in Qty. of 1 (4 ct.).
Reviews
There are no reviews yet.